ProLogium Technology signed a definitive merger agreement with Translational Capital Acquisition Corp on May 27, delivering the Taiwanese solid-state battery developer a public listing and capital to fund its first overseas gigawatt-scale manufacturing facility in Dunkirk, France. The transaction values ProLogium at approximately $2.8 billion pre-money and will inject roughly $1.4 billion in gross proceeds, assuming no SPAC redemptions and full PIPE commitment.
The merger follows more than fourteen years of development work on oxide-based solid-state lithium ceramic battery technology. ProLogium has operated a 2 GWh pilot line in Taiwan since 2022 and claims commercial readiness with automotive clients under NDA. The France plant targets 48 GWh annual capacity by 2029, positioning the company to supply European automakers within the emissions-compliance window. Construction begins fourth quarter 2026 with first production cells scheduled for late 2028.
This marks the second significant solid-state SPAC in eighteen months, after QuantumScape merged with Kensington Capital in 2020 at a $3.3 billion valuation. QuantumScape trades at roughly $1.1 billion today after multiple production delays and technical setbacks. ProLogium's oxide chemistry differs from QuantumScape's sulfide approach—oxide offers better thermal stability but lower ionic conductivity, creating a power-versus-safety trade. The Dunkirk site selection captures €1.2 billion in French battery subsidies and tariff-free EU market access, hedging against potential US-China trade friction.
Allocators should watch three dependencies. First, the SPAC redemption rate at shareholder vote—Translational needs at least 65% cash retention to meet the France capex schedule, and recent SPAC redemptions have averaged 92%. Second, ProLogium's undisclosed automotive customer announcements expected between now and close, likely targeting German OEMs given the Dunkirk location and EU subsidy structure. Third, QuantumScape's pilot production data from its San Jose line due third quarter 2026—any major setbacks will pressure the entire solid-state narrative and ProLogium's valuation multiples.
The transaction closes subject to regulatory approvals and shareholder votes, with an expected fourth quarter 2026 completion. ProLogium will trade under ticker PRGM on Nasdaq, and the company has committed to maintaining its Taoyuan headquarters and existing Taiwan production capacity through at least 2030 under the merger terms.